Skip to main content
Home
Loading...
Menu social network
  • LinkedIn
  • Facebook
  • X
  • Youtube

Menu top

  • Assistance

User account menu

  • Log in
Home

Main navigation

  • Home
  • Programme
Menu Login
Close

Main navigation mobile

  • Home
  • Programme

Menu top

  • Assistance
Menu social network
  • LinkedIn
  • Facebook
  • X
  • Youtube
Filters
Filters Close
Poster topics
Poster available until
  • x Monday 29 June 2026 (6)
  • Until platform closure (5)
Poster categories
  • Thematic Poster Session (6)
keywords
Session Reference
  • L-TPS01 (2)
  • L-TPS02 (1)
  • L-TPS03 (5)
  • L-TPS04 (1)
  • L-TPS06 (1)
  • L-TPS07 (6)
  • L-TPS08 (2)
  • L-TPS09 (3)
  • L-TPS10 (4)
  • L-TPS11 (5)
  • L-TPS12 (2)
  • L-TPS13 (4)
  • L-TPS14 (1)
  • L-TPS15 (2)
  • L-TPS16 (2)
  • L-TPS17 (4)
  • L-TPS18 (4)
  • L-TPS20 (2)
  • L-TPS22 (1)
  • L-TPS23 (1)
  • L-TPS24 (4)
  • L-TPS25 (3)
  • TPS01 (5)
  • TPS02 (2)
  • TPS03 (4)
  • TPS04 (6)
  • TPS05 (3)
  • TPS06 (4)
  • TPS07 (3)
  • TPS08 (3)
  • TPS09 (2)
  • TPS10 (6)
  • TPS11 (7)
  • TPS12 (6)
  • TPS13 (1)
  • TPS14 (6)
  • TPS15 (5)
  • TPS16 (3)
  • TPS17 (4)
  • TPS18 (2)
  • TPS20 (5)
  • TPS21 (4)
  • TPS22 (4)
  • TPS23 (3)
  • TPS24 (4)
  • TPS25 (3)
  • TPS26 (7)
  • TPS29 (1)
  • TPS30 (2)
  • TPS31 (5)
  • TPS33 (2)
  • TPS34 (5)
  • TPS35 (4)
  • TPS36 (3)
  • TPS37 (2)
  • TPS38 (4)
  • TPS39 (3)
  • TPS40 (6)
  • TPS41 (4)
  • TPS42 (3)
  • TPS43 (3)
  • TPS44 (3)
  • TPS45 (1)
  • TPS46 (1)
  • TPS47 (3)
  • TPS48 (1)
  • TPS49 (1)
  • TPS50 (4)
  • TPS51 (6)
  • TPS52 (6)
  • TPS53 (6)
  • TPS54 (3)
  • TPS55 (6)
  • TPS56 (3)
  • TPS57 (1)
  • TPS60 (3)
  • TPS61 (5)
  • TPS62 (3)
  • TPS63 (2)
  • TPS64 (3)
  • TPS65 (1)
  • TPS66 (6)
  • TPS67 (3)
  • x TPS68 (6)
  • TPS69 (1)
  • TPS70 (1)
  • TPS71 (1)
  • TPS72 (2)
  • TPS73 (3)
  • TPS74 (2)
  • TPS75 (6)
  • TPS76 (1)
  • TPS77 (1)
  • TPS78 (2)
  • TPS79 (11)
  • TPS80 (3)
  • TPS82 (7)
  • TPS83 (2)
  • TPS84 (4)
  • TPS85 (3)
  • TPS86 (1)
6 results
Thumbnail

D3.158 - Dupilumab Response in a Patient with Severe Asthma Refractory to Anti-IL5 Therapy: A Case Report

Thumbnail

D3.153 - Add-on Dupilumab therapy significantly reduces severe asthma exacerbations and emergency visits in patients with severe persistent asthma requiring oral corticosteroids for maintenance therapy: our experience in Réunion Island

Thumbnail

D3.154 - Trends in Bronchial Asthma Incidence in Crimea: Analysis from 2017-2024 with Age-Specific Insights

Thumbnail

D3.156 - Pulmonary embolism in a young asthma patient

Thumbnail

D3.159 - Early Bronchodilator Response in Asthma: When Is Testing Really Necessary?

Thumbnail

D3.161 - Efficacy and Safety of Ciclesonide in Achieving Asthma Control: Results of an Observational Multicenter Study in Real-World Clinical Practice

Download the app
The congress at your fingertips

Available on

App Store Google Play
QR Code Download
Mobile App Schedule page
Mobile App Home page
Menu social network
  • LinkedIn
  • Facebook
  • X
  • Youtube
© 2026 EAACI
Made with   by CYIM